Twinbeech Capital LP Pfizer Inc Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $46 Million - $59.8 Million	1,762,164 New	1,762,164 $50.7 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $229,759 - $265,826	6,361 New	6,361 $233,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $538,904 - $657,867	12,315 New	12,315 $539,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $1.65 Million - $2.05 Million	-36,121 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $815,822 - $1.21 Million	19,744 Added 120.56%	36,121 $2.13 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $11,147 - $14,319	284 Added 1.76%	16,377 $704,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $326,601 - $369,984	-9,095 Reduced 36.11%	16,093 $630,000
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $843,546 - $951,350	25,188 New	25,188 $913,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.